Company intelligence / Profile preview
Coordination Pharmaceuticals, Inc.
- Ownership
- Private
- Development stage
- Phase 1
Overview
Coordination Pharmaceuticals has several oncology programs in early clinical development. Its lead candidates—RiMO-301 and Bupropion Hydrochloride—are in Phase 1 trials for advanced cancers. The company’s NCP platform enables co-delivery of synergistic therapeutics and enhances checkpoint blockade immunotherapy by increasing T cell infiltration into tumors. CPI also develops RT-RDT technology to enhance X-ray radiotherapy efficacy. Early results focus on safety/tolerability and preliminary anti-tumor activity in patients with advanced tumors
- Therapeutic areas
- Oncology
- Modalities
- Nanoscale coordination polymers (NCPs)small moleculesradiotherapy-radiodynamic therapy (RT-RDT) platforms
- Industry
- Biotech
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Coordination Pharmaceuticals, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Coordination Pharmaceuticals, Inc..